MESOMARK check is now making it possible - with a simple blood test-to monitor response to treatment and to detect recurrence following treatment. This provides important information from the patient's head was racing against this aggressive cancer. "The Meso Foundation is a national research funding, patient support and advocacy organization dedicated to eradicating mesothelioma as a life-threatening illness.
Who require to take part in MESOMARK check will be asked to provide three or more blood samples. Blood samples will then be sent to the national reference laboratory for testing. Together with clinical and laboratory information obtained by your doctor, decisions about your care and treatment can be simplified. You can stop the experiment at any tim
Food and Drug Administration (FDA) approved MESOMARK assay to help monitor response to treatment in malignant mesothelioma patients. MESOMARK check marked the beginning of a new era in monitoring mesothelioma malignancies, "said Dr. W. Jeffrey Allard, Vice President and Chief Scientific Officer of Fujirebio Diagnostics." As the first in-vitro check for patients with this aggressive illness, it will permit doctors to more accurately detect recurrence and monitor treatment of patients. "
Assay MESOMARK the check kit was developed to measure levels of markers, mesothelin, in serum. Biomarkers are substances found in higher than normal concentrations in blood, urine or tissue of patients with definite types of cancer. This check can be used to monitor patients confirmed as having mesothelioma, for the repetition in patients after surgery, or to measure response to therapy.
"This diagnostic check is less than ideal for quantification of changes in tumor volume, which is the key to managing the illness," continued Allard. "As the MESOMARK results correlate with tumor volume *, it provides an indispensable tool for monitoring the status of the patient. This is how they plan to collect additional information in the future to support the use of a check to detect mesothelioma."
Who require to take part in MESOMARK check will be asked to provide three or more blood samples. Blood samples will then be sent to the national reference laboratory for testing. Together with clinical and laboratory information obtained by your doctor, decisions about your care and treatment can be simplified. You can stop the experiment at any tim
Food and Drug Administration (FDA) approved MESOMARK assay to help monitor response to treatment in malignant mesothelioma patients. MESOMARK check marked the beginning of a new era in monitoring mesothelioma malignancies, "said Dr. W. Jeffrey Allard, Vice President and Chief Scientific Officer of Fujirebio Diagnostics." As the first in-vitro check for patients with this aggressive illness, it will permit doctors to more accurately detect recurrence and monitor treatment of patients. "
Assay MESOMARK the check kit was developed to measure levels of markers, mesothelin, in serum. Biomarkers are substances found in higher than normal concentrations in blood, urine or tissue of patients with definite types of cancer. This check can be used to monitor patients confirmed as having mesothelioma, for the repetition in patients after surgery, or to measure response to therapy.
"This diagnostic check is less than ideal for quantification of changes in tumor volume, which is the key to managing the illness," continued Allard. "As the MESOMARK results correlate with tumor volume *, it provides an indispensable tool for monitoring the status of the patient. This is how they plan to collect additional information in the future to support the use of a check to detect mesothelioma."
1 komentar:
Very useful information. You have a dedicated niche. Thanks ^_^
Post a Comment